We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 14th:
Urban Outfitters, Inc. (URBN - Free Report) : This lifestyle products and services company, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 9.7% over the last 60 days.
Dillard's, Inc. (DDS - Free Report) : This retail department stores operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.
Tailored Brands, Inc. : This specialty apparel retailer, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 1.6% over the last 60 days.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Growth Stocks to Buy for June 14th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 14th:
Urban Outfitters, Inc. (URBN - Free Report) : This lifestyle products and services company, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 9.7% over the last 60 days.
Urban Outfitters, Inc. Price and Consensus
Urban Outfitters, Inc. price-consensus-chart | Urban Outfitters, Inc. Quote
Urban Outfitters has a PEG ratio of 1.57, compared with 1.89 for the industry. The company possesses a Growth Score of B.
Urban Outfitters, Inc. PEG Ratio (TTM)
Urban Outfitters, Inc. peg-ratio-ttm | Urban Outfitters, Inc. Quote
Dillard's, Inc. (DDS - Free Report) : This retail department stores operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.
Dillard's, Inc. Price and Consensus
Dillard's, Inc. price-consensus-chart | Dillard's, Inc. Quote
Dillard's has a PEG ratio of 1.62, compared with 11.46 for the industry. The company possesses a Growth Score of A.
Dillard's, Inc. PEG Ratio (TTM)
Dillard's, Inc. peg-ratio-ttm | Dillard's, Inc. Quote
Tailored Brands, Inc. : This specialty apparel retailer, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 1.6% over the last 60 days.
Tailored Brands, Inc. Price and Consensus
Tailored Brands, Inc. price-consensus-chart | Tailored Brands, Inc. Quote
Tailored Brands has a PEG ratio of 0.87, compared with 2.02 for the industry. The company possesses a Growth Score of A.
Tailored Brands, Inc. PEG Ratio (TTM)
Tailored Brands, Inc. peg-ratio-ttm | Tailored Brands, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>